PLAN ESTRATÉGICO DE INVESTIGACIÓN
LÍNEAS DE INVESTIGACIÓN
PROYECTOS DE INVESTIGACIÓN
ENSAYOS CLÍNICOS
GRUPOS COOPERATIVOS
COMUNICACIONES A CONGRESOS
PUBLICACIONES
BECAS Y RECURSOS
INVESTIGACIÓN EN OTROS LUGARES
BIBLIOGRAFIA
NUESTROS RESULTADOS

PUBLICACIONES > Año 2010
 


PLoS One. 2010 Aug 16;5(8):e12197

DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia.Alvarez S, Suela J, Valencia A, Fernández A, Wunderlich M, Agirre X, Prósper F, Martín-Subero JI, Maiques A, Acquadro F, Rodriguez Perales S, Calasanz MJ, Roman-Gómez J, Siebert R, Mulloy JC, Cervera J, Sanz MA, Esteller M, Cigudosa JC.  PMID: 20808941


Genes Chromosomes Cancer. 2010 Aug;49(8):726-32.

Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. Hasan SK, Ottone T, Schlenk RF, Xiao Y, Wiemels JL, Mitra ME, Bernasconi P, Di Raimondo F, Stanghellini MT, Marco P, Mays AN, Döhner H, Sanz MA, Amadori S, Grimwade D, Lo-Coco F. Department of Biopathology, University of 'Rome Tor Vergata', Rome, Italy.  PMID: 20544846


Bone Marrow Transplant. 2010 May;45(5):925-32. Epub 2009 Oct 5.

Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT. De la Cámara R, Jarque I, Sanz MA, Grau S, Casado MA, Sabater FJ, Carreras E.


Haematologica. 2010 Apr;95(4):589-96. Epub 2010 Feb 9.

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Oriol A, Vives S, Hernández-Rivas JM, Tormo M, Heras I, Rivas C, Bethencourt C, Moscardó F, Bueno J, Grande C, del Potro E, Guardia R, Brunet S, Bergua J, Bernal T, Moreno MJ, Calvo C, Bastida P, Feliu E, Ribera JM; Programa Español de Tratamiento en Hematologia Group.


Blood. 2010 Apr 14. [Epub ahead of print]

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Sanz MA, Montesinos P, Rayón C, Holowiecka A, de la Serna J, Milone G, de Lisa E, Brunet S, Rubio V, Ribera JM, Rivas C, Krsnik I, Bergua J, González J, Díaz-Mediavilla J, Rojas R, Manso F, Ossenkoppele G, González JD, Lowenberg B. Hospital Universitario La Fe, Valencia, Spain.


Thromb Res. 2010 Apr;125 Suppl 2:S51-4.

Open issues on bleeding and thrombosis in acute promyelocytic leukemia. Sanz MA, Montesinos P. Hospital Universitario La Fe, Valencia, Spain.

Blood. 2010 Mar 4;115(9):1690-6. Epub 2009 Dec 17.

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Adès L, Guerci A, Raffoux E, Sanz M, Chevallier P, Lapusan S, Recher C, Thomas X, Rayon C, Castaigne S, Tournilhac O, de Botton S, Ifrah N, Cahn JY, Solary E, Gardin C, Fegeux N, Bordessoule D, Ferrant A, Meyer-Monard S, Vey N, Dombret H, Degos L, Chevret S, Fenaux P; European APL Group. Hopital Avicenne, Assistance Publique-Hopitaux de Paris (AP-HP), Université Paris 13, Paris, France.


Med Clin (Barc). 2010 Apr 22.

Thrombotic thrombocytopenic purpura. [Article in Spanish] De la Rubia J, Contreras E, Del Río-Garma J. Servicio de Hematología, Hospital La Fe, Valencia, España; Universidad Católica de Valencia San Vicente Mártir, Valencia, España.


Leuk Lymphoma. 2010 Apr;51(4):680-5.

A new reliable fluorescence in situ hybridization method for identifying multiple specific cytogenetic abnormalities in acute myeloid leukemia. Valencia A, Cervera J, Such E, Ibañez M, Barragán E, Fuster O, Bolufer P, Moscardó F, Sanz MA.


Med Clin (Barc). 2010 Mar 6;134(6):268-78. Epub 2009 Oct 28.

[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group] García-Sanz R, Alegre A, Capote FJ, Hernández JM, Rosiñol L, Rubia Jde L, Sureda A, Arriba F, Bargay J, Díaz Mediavilla J, García-Laraña J, Lahuerta JJ, Mateos MV, Prósper F, San Miguel J, Bladé J. PMID: 19863972


Haematologica. 2010 Mar 10. [Epub ahead of print]

Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia. A study of the Spanish PETHEMA group. Cervantes F, López-Garrido P, Montero MI, Jonte F, Martínez J, Hernández-Boluda JC, Calbacho M, Sureda A, Pérez-Rus G, Nieto JB, Pérez-López C, Román-Gómez J, González M, Pereira A, Colomer D.Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.


Haematologica. 2010 Mar;95(3):424-31. Epub 2009 Nov 10

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.  Cervera J, Montesinos P, Hernández-Rivas JM, Calasanz MJ, Aventín A, Ferro MT, Luño E, Sánchez J, Vellenga E, Rayón C, Milone G, de la Serna J, Rivas C, González JD, Tormo M, Amutio E, González M, Brunet S, Lowenberg B, Sanz MA.


Ann Hematol. 2010 Feb;89(2):147-54. Epub 2009 Aug 19.

Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements. Remacha AF, Arrizabalaga B, Del Cañizo C, Sanz G, Villegas A


J Clin Oncol. 2010 Feb 1;28(4):562-9. Epub 2009 Dec 21.

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia. Fenaux P, Mufti GJ, Hellström-Lindberg E, Santini V, Gattermann N, Germing U, Sanz G, List AF, Gore S, Seymour JF, Dombret H, Backstrom J, Zimmerman L, McKenzie D, Beach CL, Silverman LR.


Biol Blood Marrow Transplant. 2010 Feb 6. [Epub ahead of print]

Unrelated Transplants For Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis And Study Of The Impact Hematopoietic Graft Source. Ferrá C, Sanz J, Delacámara R, Sanz G, Bermúdez A, Valcárcel D, Rovira M, Serrano D, Caballero D, Espigado L, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM. On behalf of GETH (Grupo Español de Trasplante Hematopoyético) and PETHEMA (Programa Español de Tratamiento en Hematología), Spanish Society of Hematology.


Cancer Sci. 2010 Feb;101(2):425-32. Epub 2009 Oct 29.

Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia. Martín V, Valencia A, Agirre X, Cervera J, San Jose-Eneriz E, Vilas-Zornoza A, Rodríguez-Otero P, Sanz MA, Herrera C, Torres A, Prosper F, Román-Gómez J. Hematology Department, Cellular Therapy Area, Reina Sofia Hospital, Maimonides Institute for Biomedical Research, Cordoba, Spain.


Blood. 2010 Jan 14;115(2):168-86. Epub 2009 Oct 21. 

International consensus report on the investigation and management of primary immune thrombocytopenia. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ.


Blood. 2010 Jan 21;115(3):453-74. Epub 2009 Oct 30.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD; European LeukemiaNet.


Biol Blood Marrow Transplant. 2010 Jan;16(1):86-94. Epub 2009 Sep 8.

Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia. Sanz J, Sanz MA, Saavedra S, Lorenzo I, Montesinos P, Senent L, Planelles D, Larrea L, Martín G, Palau J, Jarque I, Martínez J, de la Rubia J, Moscardó F, Romero M, Luna I, Montava A, Cañabate S, Sanz GF.


Transfus Apher Sci. 2010 Dec;43(3):299-303. Epub 2010 Oct 12.

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.de la Rubia J, Moscardó F, Gómez MJ, Guardia R, Rodríguez P, Sebrango A, Zamora C, Debén G, Goterris R, López R, Peña F, Pujol M, Vidaller A, Del Río-Garma J, Sanz MA; Grupo Español de Aféresis.


J Clin Oncol. 2010 Aug 20;28(24):3872-9. Epub 2010 Jul 12.

Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy. Montesinos P, González JD, González J, Rayón C, de Lisa E, Amigo ML, Ossenkoppele GJ, Peñarrubia MJ, Pérez-Encinas M, Bergua J, Debén G, Sayas MJ, de la Serna J, Ribera JM, Bueno J, Milone G, Rivas C, Brunet S, Löwenberg B, Sanz M.

Clonal evolution in patients with chronic lymphocytic leukemia.

Umbilical cord blood transplantation from unrelated donors in adult patients with chronic myeloid leukaemia Loscertales J, Arranz E, Sanz MA, Blas C, Gil-Fernández JJ, Burgaleta C, Alegre A. Best Pract Res Clin Haematol. 2010 Jun;23(2):217-22. Review..Sanz J, Sanz GF.

Med Clin (Barc)

Profilaxis antifúngicas en pacientes oncohematológicos De la Cámara R, Mensa J, Carreras E, Cuenca Estrella M, García Rodríguez JA, Gobernado M, Picazo J, Aguado JM, Sanz MA

Haematologica. 2010 Nov;95(11):1913-20. Epub 2010 Jul 27.

Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.Lahuerta JJ, Mateos MV, Martínez-López J, Grande C, de la Rubia J, Rosiñol L, Sureda A, García-Laraña J, Díaz-Mediavilla J, Hernández-García MT, Carrera D, Besalduch J, de Arriba F, Oriol A, Escoda L, García-Frade J, Rivas-González C, Alegre A, Bladé J, San Miguel JF; Grupo Español de MM and Programa para el Estudio de la Terapéutica en Hemopatía Maligna Cooperative Study Groups.

Lancet Oncol. 2010 Jul;11(7):653-60.

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE; Center for International Blood and Marrow Transplant Research; Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation); National Cord Blood Program of the New York Blood Center.

Leuk Res. 2010 Nov;34(11):1410-6. Epub 2010 Jul 6.

Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion.Fenaux P, Bowen D, Gattermann N, Hellström-Lindberg E, Hofmann WK, Pfeilstöcker M, Sanz G, Santini V.Hôpital Avicenne, Assistance Publique, Hôpitaux de Paris and Paris 13 University, Bobigny, France.


Eur J Haematol. 2010 Oct;85(4):363-5. doi: 10.1111/j.1600-0609.2010.01500.x. Epub 2010 Aug 30.

Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study. De la Rubia J, Roig M, Ibáñez A, García I, Vera JA, Aguilar C, del Campo R, González N, Martínez R, Palomera L, Picón I, Rodríguez JN, Sanz MA.

Biol Blood Marrow Transplant. 2010 Nov;16(11):1589-95. Epub 2010 May

27.Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.Sanz J, Montesinos P, Saavedra S, Lorenzo I, Senent L, Planelles D, Larrea L, Martín G, Palau J, Jarque I, Martínez J, de la Rubia J, Moscardó F, Martinez D, Gómez I, López M, Sanz MA, Sanz GF.


Ann Hematol. 2010 Nov;89(11):1073-80. Epub 2010 Jun 5.

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, Gallur L, Jarque I, Caballero D, Díaz-Mediavilla J, Bustelos R, Fernández-Aceñero MJ, Cabrera JR; Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA.


Clin Cancer Res. 2010 Jun 15;16(12):3260-9. Epub 2010 Jun 8.

Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma. Mateos MV, Cibeira MT, Richardson PG, Prosper F, Oriol A, de la Rubia J, Lahuerta JJ, García-Sanz R, Extremera S, Szyldergemajn S, Corrado C, Singer H, Mitsiades CS, Anderson KC, Bladé J, San Miguel J.

Med Clin (Barc). 2010 Feb 20;134(5):222-33. Epub 2009 Dec 29.

[Antifungal prophylaxis in oncohematologic patients: Literature review and recommendations].Cámara Rde L, Mensa J, Carreras E, Cuenca Estrella M, García Rodríguez JA, Gobernado M, Picazo J, Aguado JM, Sanz MA.

Clin Lymphoma Myeloma Leuk. 2010 Oct 1;10:S122-6.

Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy. Tallman M, Douer D, Gore S, Powell BL, Ravandi F, Rowe J, Ranganathan A, Sanz MA.

Med Oncol. 2010 Sep;27(3):702-7. Epub 2009 Aug 8.

High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent  ATRA.Aljurf M, Al Qurashi F, Al Mohareb F, , Al Sharif F, Al Zahrani H, Al Shanqeeti A, Owaidah T, Iqbal A, Zaidi SZ, Nurgat ZA, Sanz M, .

Leuk Lymphoma. 2010 Nov;51(11):1960-1.

DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?de la Rubia J, Such E. Hematology Service, Hospital La Fe, Valencia, Spain.PMID: 21077744

Blood. 2010 Oct 8. [Epub ahead of print]

A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia. Such E, Cervera J, Valencia A, Barragán E, Ibañez M, Luna I, Fuster O, Perez-Sirvent ML, Senent L, Sempere A, Martinez J, Martín-Aragonés G, Sanz MA.Department of Hematology, Hospital Universitario La Fe, Valencia, SpainPMID: 20935257

Int J Gen Med. 2010 Oct 5;3:305-11

Long-term management of chronic immune thrombocytopenic purpura in adults.Palau J, Jarque I, Sanz MA.PMID: 21042569 [PubMed]

Blood. 2010 Oct 8.

Does microgranular variant morphology of acute promyelocytic leukemia independently predict for a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group. Tallman MS, Kim HT, Montesinos P, Appelbaum FR, de la Serna J, Bennett JM, Deben G, Bloomfield CD, Gonzalez J, Feusner JH, Gonzalez M, Gallagher R, Gonzalez-San Miguel JD, Larson RA, Milone G, Paietta E, Rayon C, Rowe JM, Rivas C, Schiffer CA, Vellenga E, Shepherd L, Slack JL, Wiernik PH, Willman CL, Sanz MA.PMID: 20858857

Leuk Res. 2010 Sep 21. [Epub ahead of print]

Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts.Valencia A, Cervera J, Such E, Ibañez M, Gómez I, Luna I, Senent L, Oltra S, Sanz MA, Sanz GF.Department of Hematology, Hospital Universitario La Fe, Avda. Campanar 21, 46009 Valencia, Spain.PMID: 20864173

Secretaría del Servicio de Hematología · Hospital General, Planta Baja · Hospital Universitario La Fe · Avda. Campanar 21 · 46021 Valencia. · Tfno.:963 862 745 · Fax: 961 973 281
Aviso legal · Mapa web
[X] Cerrar